Associate Global Medical Director – Semaglutide Obesity

Novo Nordisk

Tytuł pracy:

Associate Global Medical Director – Semaglutide Obesity

Firma

Novo Nordisk

Opis stanowiska

By continuing to use and navigate this website, you are agreeing to the use of cookies.
Accept ClosePress Tab to Move to Skip to Content LinkSearch by KeywordSearch by LocationLoading…CategorySelect how often (in days) to receive an alert:×Select how often (in days) to receive an alert:Associate Global Medical Director – Semaglutide ObesityCategory: Medical AffairsLocation:Søborg, Capital Region of Denmark, DKAre you a highly experienced medical professional with a keen interest in obesity and other cardiometabolic diseases? Are you in search of an opportunity to apply your medical knowledge, leadership abilities, and interpersonal skills? Does the prospect of engaging in strategic discussions and scientific exchange intrigue you?Then don’t miss this opportunity, as we are actively looking for individual with exceptional personality to join and strengthen our Semaglutide Obesity team within the Global Medical Affairs (GMA) Obesity VP area. Apply now for this exciting job opportunity!The Position
As a key member of our team, you will become part of an enthusiastic and diverse international group, comprising motivated professionals with extensive clinical, research, and pharmaceutical expertise in both global and regional/local settings. Collectively, our dedication lies in advancing clinical drug development, fostering scientific discussions, promoting medical education, and establishing proficient communication with medical leaders. Working together, these pursuits drive and inspire our team, ultimately to improve lives for people with chronic conditionsLeveraging your vast expertise, you will play a crucial position, operating independently to lead strategic discussions and decision-making processes for key projects related to semaglutide in obesity, cardiovascular disease and other related complications.Your responsibilities will include:

  • Shape the strategy by providing patient and medical perspectives (insights for strategy
  • Leading strategic projects within the product specific committees.
  • Collaborating closely with key stakeholders from various cross-functional teams.
  • Working cross-functionally to generate, interpret, and effectively communicate scientific data emerging on all phases of clinical trials of business development assets
  • Successfully collaborate and communicate with Key Opinion Leaders (KOLs) and internal stakeholders, including regional teams, affiliates, marketing, patient access, development, and regulatory affairs.

The position is based in Copenhagen, Denmark. Worldwide travel is a requirement in alignment with our Circular for Zero policy.QualificationsWe are looking for experienced medical professional who, personally, fosters genuine teamwork, and nurturing positive relationships within a diverse and dynamic international environment as of utmost importance. Our team comprises diverse individuals with excellent interpersonal skills along with friendly demeanour, and it’s important for us to add personnel who will seamlessly integrate.A successful candidate is expected to have:

  • Medical background (MD/PhD) is desired
  • Minimum 5 years of clinical and/or pharmaceutical industry experience within Medical Affairs.
  • Professional focus in obesity and/or cardiometabolic disease is considered a plus.
  • Strong communication and presentation skills, as well as the ability to lead and drive cross-functional collaboration with internal and external stakeholders.
  • Strategic and critical thinking that allow you to anticipate opportunities and take initiative to address them effectively.
  • Fluency in spoken and written English is essential.

About the Department
The Semaglutide Obesity team is part of the Obesity VP area in Global Medical Affairs, located in Søborg, near Copenhagen in Denmark. Our department is focused on building and executing medical strategies for semaglutide in obesity, CVD and related complications and advance the field of obesity care through scientific exchange and dialogue with the external medical community.Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development to manufacturing, marketing, and sales – we’re all working to drive change in obesity and improve care for patients.Contact
For further information, please contact Søren Kruse Lilleøre +45 3079 2918.Deadline
10. november 2024.You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.

Oczekiwane wynagrodzenie

Lokalizacja

Søborg, Hovedstaden

Data pracy

Wed, 23 Oct 2024 07:02:19 GMT

Aby pomóc nam śledzić nasze działania rekrutacyjne, prosimy wskazać w swoim e-mailu/liście motywacyjnym, gdzie (jobsineu.net) widziałeś tę ofertę pracy.

To apply for this job please visit jobviewtrack.com.

Job Location